Login to Your Account

Other News To Note

Thursday, February 16, 2012

• RegeneRx Biopharmaceuticals Inc., of Rockville, Md., said researchers have shown that Thymosin beta 4 provided both neuroprotection and neurorestoration in a rat model of traumatic brain injury. Compared with placebo, the drug, initiated six hours post-injury, statistically significantly improved sensorimotor functional recovery and spatial learning, reduced cortical lesion volume and hippocampal cell loss.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription